Director · Silence Therapeutics plc · Silence Therapeutics plc — Share Option (Right to Buy)
Side
A
Value
—
Shares
90.0K
Price
—
Executed
Dec 22, 2025
Disclosed
Dec 22, 2025
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Dec 22 executedDec 22, 2025 disclosed
SLN · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Silence Therapeutics plc — Share Option (Right to Buy)
Ticker
SLN
Shares
90.0K
Price per share
$0
Execution date (reported)
Dec 22, 2025
Owned after transaction
90.0K shares
Days from execution to publication
0
What this establishes
Ede-Golightly James filed this Form 4 reporting a grant or award of SLN on Dec 22, 2025. It became public on Dec 22, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Ede-Golightly Jamescik:0002048873
Issuer
Silence Therapeutics plccik:0001479615
Revision history · 0
No field has changed since this record was first ingested.
